Michael Weiser, Director at Hana Biosciences Inc (HNAB), bought 10,000 shares at $0.84 ($8K) on 2008-05-15, disclosed to the SEC on 2008-05-15.
Open-market purchase of $8k HNAB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.84 | 6,000 | $5K | 59.7% |
| 2 | $0.85 | 4,000 | $3K | 40.3% |
| Total | $0.84 avg | 10,000 | $8K | 100% |
| Filing → |
| ZIOP | SELL | 2011-05-26 | $98K | — | Filing → |
| CHTP | BUY | 2008-10-06 | $3K | — | Filing → |
| CHTP | BUY | 2008-09-24 | $4K | — | Filing → |